adenosine monophosphate has been researched along with pyruvaldehyde in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Feng, L; Han, X; Huang, Y; Peng, C; Rao, L; Ren, Y; Song, R; Su, C; Wan, J; Wei, L; Xu, Y | 1 |
Gugliucci, A | 2 |
Berney, M; Blanchard, JS; Hartman, TE; Jacobs, WR; Noy, T; Rhee, KY; Vergnolle, O | 1 |
4 other study(ies) available for adenosine monophosphate and pyruvaldehyde
Article | Year |
---|---|
Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
Topics: Allosteric Site; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Fructose-Bisphosphatase; Glucose; Hepatocytes; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Molecular Dynamics Simulation; Molecular Structure; Rats; Structure-Activity Relationship | 2019 |
"Blinding" of AMP-dependent kinase by methylglyoxal: a mechanism that allows perpetuation of hepatic insulin resistance?
Topics: Adenosine Monophosphate; Insulin Resistance; Liver; Protein Binding; Protein Kinases; Pyruvaldehyde | 2009 |
Central Role of Pyruvate Kinase in Carbon Co-catabolism of Mycobacterium tuberculosis.
Topics: Aconitic Acid; Adenosine Monophosphate; Allosteric Regulation; Animals; Bacterial Proteins; Carbon; Citric Acid; Culture Media; Enzyme Activation; Fatty Acids, Volatile; Female; Gene Deletion; Gene Expression; Glucose; Glucose-6-Phosphate; Glutamic Acid; Glycolysis; Isocitrate Dehydrogenase; Ketoglutaric Acids; Mice; Mice, SCID; Mycobacterium tuberculosis; Phosphoenolpyruvate; Pyruvaldehyde; Pyruvate Kinase; Survival Analysis; Tuberculosis | 2016 |
Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Topics: Adenosine Monophosphate; Adenylate Kinase; Allosteric Site; AMP-Activated Protein Kinases; Animals; Binding Sites; Diabetes Mellitus, Type 2; Fatty Liver; Fructose; Gene Silencing; Glucose; Humans; Insulin Resistance; Lipogenesis; Liver; Metabolic Syndrome; Models, Theoretical; Phosphorylation; Portal Vein; Pyruvaldehyde; Stochastic Processes; Uric Acid | 2016 |